X. Jin, D. Bauer, S. Tuttleton, S. Lewin, A. Gettie et al., T Cell Depletion in Simian Immunodeficiency Virus???infected Macaques, The Journal of Experimental Medicine, vol.41, issue.6, pp.991-998, 1999.
DOI : 10.1007/BF00918085

R. Koup, J. Safrit, Y. Cao, C. Andrews, G. Mcleod et al., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J. Virol, vol.68, pp.4650-4655, 1994.

J. Schmitz, M. Kuroda, S. Santra, V. Sasseville, M. Simon et al., Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes, Science, vol.283, issue.5403, pp.857-860, 1999.
DOI : 10.1126/science.283.5403.857

N. Goonetilleke, M. Liu, J. Salazar-gonzalez, G. Ferrari, E. Giorgi et al., The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection, The Journal of Experimental Medicine, vol.210, issue.6, pp.1253-1272, 2009.
DOI : 10.1084/jem.20071261

P. Mudd, M. Martins, A. Ericsen, D. Tully, K. Power et al., Vaccine-induced CD8+ T cells control AIDS virus replication, Nature, vol.4, issue.7422, pp.129-133, 2012.
DOI : 10.1038/nature11443

J. Mellors, C. Rinaldo, . Jr, P. Gupta, R. White et al., Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma, Science, vol.272, issue.5265, pp.1167-1170, 1996.
DOI : 10.1126/science.272.5265.1167

H. Streeck, J. Jolin, Y. Qi, B. Yassine-diab, R. Johnson et al., Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells, Journal of Virology, vol.83, issue.15, pp.7641-7648, 2009.
DOI : 10.1128/JVI.00182-09

M. Carrington and B. Walker, Immunogenetics of Spontaneous Control of HIV, Annual Review of Medicine, vol.63, issue.1, pp.131-145, 2012.
DOI : 10.1146/annurev-med-062909-130018

P. Goulder and B. Walker, HIV and HLA Class I: An Evolving Relationship, Immunity, vol.37, issue.3, pp.426-440, 2012.
DOI : 10.1016/j.immuni.2012.09.005
URL : http://doi.org/10.1016/j.immuni.2012.09.005

W. Dinges, J. Richardt, D. Friedrich, E. Jalbert, Y. Liu et al., Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype, Journal of Virology, vol.84, issue.9, pp.4461-4468, 2010.
DOI : 10.1128/JVI.02438-09

C. Geldmacher, J. Currier, E. Herrmann, A. Haule, E. Kuta et al., CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients, Journal of Virology, vol.81, issue.5, pp.2440-2448, 2007.
DOI : 10.1128/JVI.01847-06

P. Kiepiela, K. Ngumbela, C. Thobakgale, D. Ramduth, I. Honeyborne et al., CD8+ T-cell responses to different HIV proteins have discordant associations with viral load, Nature Medicine, vol.53, issue.1, pp.46-53, 2007.
DOI : 10.1038/nm1520

H. Streeck, M. Lichterfeld, G. Alter, A. Meier, N. Teigen et al., Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles, Journal of Virology, vol.81, issue.14, pp.7725-7731, 2007.
DOI : 10.1128/JVI.00708-07

V. Novitsky, P. Gilbert, T. Peter, M. Mclane, S. Gaolekwe et al., Association TRIM5 and Control of HIV-1 Replication, 2003.

R. Zuniga, A. Lucchetti, P. Galvan, S. Sanchez, C. Sanchez et al., Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control, Journal of Virology, vol.80, issue.6, pp.3122-3125, 2006.
DOI : 10.1128/JVI.80.6.3122-3125.2006

C. Boutwell, C. Rowley, and M. Essex, Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein, Journal of Virology, vol.83, issue.6, pp.2460-2468, 2009.
DOI : 10.1128/JVI.01970-08

H. Crawford, W. Lumm, A. Leslie, M. Schaefer, D. Boeras et al., Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703???positive individuals and their transmission recipients, The Journal of Experimental Medicine, vol.158, issue.4, pp.909-921, 2009.
DOI : 10.1089/aid.1994.10.343

H. Crawford, J. Prado, A. Leslie, S. Hue, I. Honeyborne et al., Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.81, issue.15, pp.8346-8351, 2007.
DOI : 10.1128/JVI.00465-07

J. Martinez-picado, J. Prado, E. Fry, K. Pfafferott, A. Leslie et al., Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.80, issue.7, pp.3617-3623, 2006.
DOI : 10.1128/JVI.80.7.3617-3623.2006

T. Miura, M. Brockman, A. Schneidewind, M. Lobritz, F. Pereyra et al., HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition, Journal of Virology, vol.83, issue.6, pp.2743-2755, 2009.
DOI : 10.1128/JVI.02265-08

A. Schneidewind, M. Brockman, S. J. Wang, Y. Chen, H. Suscovich et al., Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid, Journal of Virology, vol.82, issue.11, pp.5594-5605, 2008.
DOI : 10.1128/JVI.02356-07

A. Schneidewind, M. Brockman, Y. R. Adam, R. Li, B. et al., Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication, Journal of Virology, vol.81, issue.22, pp.12382-12393, 2007.
DOI : 10.1128/JVI.01543-07

J. Wright, V. Naidoo, Z. Brumme, J. Prince, D. Claiborne et al., Impact of HLA-B*81-Associated Mutations in HIV-1 Gag on Viral Replication Capacity, Journal of Virology, vol.86, issue.6, pp.3193-3199, 2012.
DOI : 10.1128/JVI.06682-11

J. Almeida, D. Price, L. Papagno, Z. Arkoub, D. Sauce et al., T cells is reflected by their avidity, polyfunctionality, and clonal turnover, The Journal of Experimental Medicine, vol.93, issue.10, pp.2473-2485, 2007.
DOI : 10.1016/S0022-1759(02)00195-3

H. Chen, Z. Ndhlovu, D. Liu, L. Porter, J. Fang et al., TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection, Nature Immunology, vol.172, issue.7, pp.691-700, 2012.
DOI : 10.1038/ni.2342

V. Dahirel, K. Shekhar, F. Pereyra, T. Miura, M. Artyomov et al., Coordinate linkage of HIV evolution reveals regions of immunological vulnerability, Proceedings of the National Academy of Sciences, vol.108, issue.28, pp.11530-11535, 2011.
DOI : 10.1073/pnas.1105315108

C. Perez, M. Larsen, R. Gustafsson, M. Norstrom, A. Atlas et al., Broadly Immunogenic HLA Class I Supertype-Restricted Elite CTL Epitopes Recognized in a Diverse Population Infected with Different HIV-1 Subtypes, The Journal of Immunology, vol.180, issue.7, pp.5092-5100, 2008.
DOI : 10.4049/jimmunol.180.7.5092

C. Berger, N. Frahm, D. Price, B. Mothe, M. Ghebremichael et al., High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control, Journal of Virology, vol.85, issue.18, pp.9334-9345, 2011.
DOI : 10.1128/JVI.00460-11

M. Betts, M. Nason, S. West, D. Rosa, S. Migueles et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006.
DOI : 10.1182/blood-2005-12-4818

B. Vingert, D. Benati, O. Lambotte, P. De-truchis, L. Slama et al., HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term, Journal of Virology, vol.86, issue.19, pp.10661-10674, 2012.
DOI : 10.1128/JVI.00056-12
URL : https://hal.archives-ouvertes.fr/pasteur-00733917

C. Day, D. Kaufmann, P. Kiepiela, J. Brown, E. Moodley et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006.
DOI : 10.1126/science.274.5284.94

A. Hersperger, F. Pereyra, M. Nason, K. Demers, P. Sheth et al., Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control, PLoS Pathogens, vol.16, issue.5, 2010.
DOI : 10.1371/journal.ppat.1000917.s014

S. Migueles, A. Laborico, W. Shupert, M. Sabbaghian, R. Rabin et al., HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002.
DOI : 10.1038/ni845

S. Migueles, C. Osborne, C. Royce, A. Compton, R. Joshi et al., Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control, Immunity, vol.29, issue.6, pp.1009-1021, 2008.
DOI : 10.1016/j.immuni.2008.10.010

S. Deeks and B. Walker, Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.
DOI : 10.1016/j.immuni.2007.08.010

J. Theze, L. Chakrabarti, B. Vingert, F. Porichis, and D. Kaufmann, HIV controllers: A multifactorial phenotype of spontaneous viral suppression, Clinical Immunology, vol.141, issue.1, pp.15-30, 2011.
DOI : 10.1016/j.clim.2011.07.007

J. Blankson, Control of HIV-1 replication in elite suppressors, Discov. Med, vol.9, pp.261-266, 2010.

E. Battivelli, J. Migraine, D. Lecossier, P. Yeni, F. Clavel et al., Gag Cytotoxic T Lymphocyte Escape Mutations Can Increase Sensitivity of HIV-1 to Human TRIM5??, Linking Intrinsic and Acquired Immunity, Journal of Virology, vol.85, issue.22, pp.11846-11854, 2011.
DOI : 10.1128/JVI.05201-11

M. Stremlau, M. Perron, M. Lee, Y. Li, B. Song et al., Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5?? restriction factor, Proceedings of the National Academy of Sciences, vol.103, issue.14, pp.5514-5519, 2006.
DOI : 10.1073/pnas.0509996103

J. Kim, C. Tipper, and J. Sodroski, Role of TRIM5?? RING Domain E3 Ubiquitin Ligase Activity in Capsid Disassembly, Reverse Transcription Blockade, and Restriction of Simian Immunodeficiency Virus, Journal of Virology, vol.85, issue.16, pp.8116-8132, 2011.
DOI : 10.1128/JVI.00341-11

T. Pertel, S. Hausmann, D. Morger, S. Zuger, J. Guerra et al., TRIM5 is an innate immune sensor for the retrovirus capsid lattice, Nature, vol.469, issue.7343, pp.361-365, 2011.
DOI : 10.1038/nature09976
URL : https://hal.archives-ouvertes.fr/pasteur-01402086

W. Johnson and S. Sawyer, Molecular evolution of the antiretroviral TRIM5 gene, Immunogenetics, vol.353, issue.Suppl 8, pp.163-176, 2009.
DOI : 10.1007/s00251-009-0358-y

M. Stremlau, C. Owens, M. Perron, M. Kiessling, P. Autissier et al., The cytoplasmic body component TRIM5?? restricts HIV-1 infection in Old World monkeys, Nature, vol.427, issue.6977, pp.848-853, 2004.
DOI : 10.1038/nature02343

E. Battivelli, D. Lecossier, S. Matsuoka, J. Migraine, F. Clavel et al., Strain-Specific Differences in the Impact of Human TRIM5??, Different TRIM5?? Alleles, and the Inhibition of Capsid-Cyclophilin A Interactions on the Infectivity of HIV-1, Journal of Virology, vol.84, issue.21, pp.11010-11019, 2010.
DOI : 10.1128/JVI.00758-10

T. Hatziioannou, D. Perez-caballero, S. Cowan, and P. Bieniasz, Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells, Journal of Virology, vol.79, issue.1, pp.176-183, 2005.
DOI : 10.1128/JVI.79.1.176-183.2005

Z. Keckesova, L. Ylinen, and G. Towers, Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5?? Antiviral Activity, Journal of Virology, vol.80, issue.10, pp.4683-4690, 2006.
DOI : 10.1128/JVI.80.10.4683-4690.2006

E. Sokolskaja, L. Berthoux, and J. Luban, Cyclophilin A and TRIM5?? Independently Regulate Human Immunodeficiency Virus Type 1 Infectivity in Human Cells, Journal of Virology, vol.80, issue.6, pp.2855-2862, 2006.
DOI : 10.1128/JVI.80.6.2855-2862.2006

M. Stremlau, B. Song, H. Javanbakht, M. Perron, and J. Sodroski, Cyclophilin A: An auxiliary but not necessary cofactor for TRIM5?? restriction of HIV-1, Virology, vol.351, issue.1, pp.112-120, 2006.
DOI : 10.1016/j.virol.2006.03.015

N. Letvin, S. Rao, D. Montefiori, M. Seaman, Y. Sun et al., Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys, Science Translational Medicine, vol.3, issue.81, pp.81-117, 2011.
DOI : 10.1126/scitranslmed.3002351

S. Lim, T. Chan, R. Gelman, J. Whitney, O. Brien et al., Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys, PLoS Genetics, vol.58, issue.12, 2010.
DOI : 10.1371/journal.pgen.1000997.s001

S. Lim, R. T. Chan, T. Whitney, J. Kim, J. Sodroski et al., TRIM5alpha modulates immunodeficiency virus control in rhesus monkeys, PLoS Pathog, 2010.

T. Rogers, S. Lim, T. Sundsvold, T. Chan, A. Hsu et al., Variability in a dominant block to SIV early reverse transcription in rhesus monkey cells predicts in vivo viral replication and time to death, Virology Journal, vol.7, issue.1, p.79, 2010.
DOI : 10.1186/1743-422X-7-79

M. Jordan and F. Wurm, Transfection of adherent and suspended cells by calcium phosphate, Methods, vol.33, issue.2, pp.136-143, 2004.
DOI : 10.1016/j.ymeth.2003.11.011

S. Matsuoka, E. Dam, D. Lecossier, F. Clavel, and A. Hance, Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type, Retrovirology, vol.6, issue.1, p.21, 2009.
DOI : 10.1186/1742-4690-6-21

T. Nora, F. Bouchonnet, B. Labrosse, C. Charpentier, F. Mammano et al., Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses, Retrovirology, vol.5, issue.1, p.23, 2008.
DOI : 10.1186/1742-4690-5-23

C. Lacabaratz-porret, A. Urrutia, J. Doisne, C. Goujard, C. Deveau et al., Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)???Specific T Cell Responses in Primary HIV Infection, The Journal of Infectious Diseases, vol.187, issue.5, pp.748-757, 2003.
DOI : 10.1086/368333

P. Matthews, A. Leslie, A. Katzourakis, H. Crawford, R. Payne et al., HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering, Journal of Virology, vol.83, issue.9, pp.4605-4615, 2009.
DOI : 10.1128/JVI.02017-08
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668443

A. Mcmichael and P. Klenerman, HIV/AIDS: HLA Leaves Its Footprints on HIV, Science, vol.296, issue.5572, pp.1410-1411, 2002.
DOI : 10.1126/science.1072492

D. Descamps, M. Chaix, B. Montes, S. Pakianather, C. Charpentier et al., Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France, Journal of Antimicrobial Chemotherapy, vol.65, issue.12, pp.2620-2627, 2001.
DOI : 10.1093/jac/dkq380

H. Fleury, P. Recordon-pinson, A. Caumont, M. Faure, P. Roques et al., HIV Type 1 Diversity in France, 1999???2001: Molecular Characterization of non-B HIV Type 1 Subtypes and Potential Impact on Susceptibility to Antiretroviral Drugs, AIDS Research and Human Retroviruses, vol.19, issue.1, pp.41-47, 1999.
DOI : 10.1089/08892220360473952

M. Brockman, A. Schneidewind, M. Lahaie, A. Schmidt, T. Miura et al., Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A, Journal of Virology, vol.81, issue.22, pp.12608-12618, 2007.
DOI : 10.1128/JVI.01369-07

A. Leslie, K. Pfafferott, P. Chetty, R. Draenert, M. Addo et al., HIV evolution: CTL escape mutation and reversion after transmission, Nature Medicine, vol.10, issue.3, pp.282-289, 2004.
DOI : 10.1038/nm992

M. Altfeld, M. Addo, E. Rosenberg, F. Hecht, P. Lee et al., Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection, AIDS, vol.17, issue.18, pp.2581-2591, 2003.
DOI : 10.1097/00002030-200312050-00005

M. Altfeld, E. Kalife, Y. Qi, H. Streeck, M. Lichterfeld et al., HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1, PLoS Medicine, vol.76, issue.10, 2006.
DOI : 10.1371/journal.pmed.0030403.t002

A. Schneidewind, Y. Tang, M. Brockman, E. Ryland, J. Dunkley-thompson et al., Maternal Transmission of Human Immunodeficiency Virus Escape Mutations Subverts HLA-B57 Immunodominance but Facilitates Viral Control in the Haploidentical Infant, Journal of Virology, vol.83, issue.17, pp.8616-8627, 2009.
DOI : 10.1128/JVI.00730-09

K. Ladell, M. Hashimoto, M. Iglesias, P. Wilmann, J. Mclaren et al., A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8+ T Cells, Immunity, vol.38, issue.3, pp.425-436, 2013.
DOI : 10.1016/j.immuni.2012.11.021

A. Kelleher, C. Long, E. Holmes, R. Allen, J. Wilson et al., Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27???Restricted Cytotoxic T Lymphocyte Responses, The Journal of Experimental Medicine, vol.46, issue.3, pp.375-386, 2001.
DOI : 10.1038/354453a0

A. Schneidewind, Z. Brumme, C. Brumme, K. Power, L. Reyor et al., Transmission and Long-Term Stability of Compensated CD8 Escape Mutations, Journal of Virology, vol.83, issue.8, pp.3993-3997, 2009.
DOI : 10.1128/JVI.01108-08

H. Streeck, B. Li, A. Poon, A. Schneidewind, A. Gladden et al., Immune-driven recombination and loss of control after HIV superinfection, The Journal of Experimental Medicine, vol.68, issue.8, pp.1789-1796, 2008.
DOI : 10.1371/journal.ppat.0030177

M. Feeney, Y. Tang, K. Roosevelt, A. Leslie, K. Mcintosh et al., Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing Child, Journal of Virology, vol.78, issue.16, pp.8927-8930, 2004.
DOI : 10.1128/JVI.78.16.8927-8930.2004

P. Goulder, R. Phillips, R. Colbert, S. Mcadam, G. Ogg et al., Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS, Nature Medicine, vol.89, issue.2, pp.212-217, 1997.
DOI : 10.1038/nm0496-405

J. Bailey, T. Williams, R. Siliciano, and J. Blankson, elite suppressors despite CTL escape mutations, The Journal of Experimental Medicine, vol.69, issue.5, pp.1357-1369, 2006.
DOI : 10.1089/08892220260235425

C. Durand, O. Connell, K. Apuzzo, L. Langan, S. Imteyaz et al., HIV-1 Gag evolution in recently infected human leukocyte antigen-B*57 patients with low-level viremia, AIDS, vol.24, pp.2405-2408, 2010.
DOI : 10.1097/QAD.0b013e32833d8a38

O. Connell, K. Brennan, T. Bailey, J. Ray, S. Siliciano et al., Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus, Journal of Virology, vol.84, issue.14, pp.7018-7028, 2010.
DOI : 10.1128/JVI.00548-10

S. Migueles, A. Laborico, H. Imamichi, W. Shupert, R. C. Mclaughlin et al., The differential ability of HLA B*5701 long-term nonprogressors TRIM5 and Control of HIV-1 Replication, 2003.

A. Kirmaier, F. Wu, R. Newman, L. Hall, J. Morgan et al., TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species, PLoS Biology, vol.16, issue.Suppl 8, 2010.
DOI : 10.1371/journal.pbio.1000462.s001

J. Barbour, F. Hecht, T. Wrin, M. Segal, C. Ramstead et al., Replication Capacity among Treatment???Naive Adults in Early HIV???1 Infection, The Journal of Infectious Diseases, vol.190, issue.2, pp.251-256, 2004.
DOI : 10.1086/422036

S. Deeks, T. Wrin, T. Liegler, R. Hoh, M. Hayden et al., Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia, New England Journal of Medicine, vol.344, issue.7, pp.472-480, 2001.
DOI : 10.1056/NEJM200102153440702

M. Nijhuis, S. Deeks, and C. Boucher, Implications of antiretroviral resistance on viral fitness, Current Opinion in Infectious Diseases, vol.14, issue.1, pp.23-28, 2001.
DOI : 10.1097/00001432-200102000-00005

M. Norstrom, M. Buggert, J. Tauriainen, W. Hartogensis, M. Prosperi et al., Combination of Immune and Viral Factors Distinguishes Low-Risk versus High-Risk HIV-1 Disease Progression in HLA-B*5701 Subjects, Journal of Virology, vol.86, issue.18, pp.9802-9816, 2012.
DOI : 10.1128/JVI.01165-12

M. Feeney, Y. Tang, K. Pfafferott, K. Roosevelt, R. Draenert et al., HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response, The Journal of Immunology, vol.174, issue.12, pp.7524-7530, 2005.
DOI : 10.4049/jimmunol.174.12.7524

U. Schwedler, K. Stray, J. Garrus, and W. Sundquist, Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein, Journal of Virology, vol.77, issue.9, pp.5439-5450, 2003.
DOI : 10.1128/JVI.77.9.5439-5450.2003

N. Rahm, D. Gfeller, J. Snoeck, R. Martinez, P. Mclaren et al., Susceptibility and adaptation to human TRIM5?? alleles at positive selected sites in HIV-1 capsid, Virology, vol.441, issue.2, pp.162-170, 2013.
DOI : 10.1016/j.virol.2013.03.021

S. Sewram, R. Singh, E. Kormuth, L. Werner, K. Mlisana et al., Human TRIM5?? Expression Levels and Reduced Susceptibility to HIV???1 Infection, The Journal of Infectious Diseases, vol.199, issue.11, pp.1657-1663, 2009.
DOI : 10.1086/598861

R. Cagliani, M. Fumagalli, M. Biasin, L. Piacentini, S. Riva et al., Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene, Human Genetics, vol.122, issue.6, pp.577-588, 2010.
DOI : 10.1007/s00439-010-0884-6

L. Carthagena, M. Parise, M. Ringeard, M. Chelbi-alix, U. Hazan et al., Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities, Retrovirology, vol.5, issue.1, p.59, 2008.
DOI : 10.1186/1742-4690-5-59

R. Sakuma, A. Mael, and Y. Ikeda, Alpha Interferon Enhances TRIM5??-Mediated Antiviral Activities in Human and Rhesus Monkey Cells, Journal of Virology, vol.81, issue.18, pp.10201-10206, 2007.
DOI : 10.1128/JVI.00419-07

E. Battivelli, J. Migraine, D. Lecossier, S. Matsuoka, D. Perez-bercoff et al., Modulation of TRIM5?? Activity in Human Cells by Alternatively Spliced TRIM5 Isoforms, Journal of Virology, vol.85, issue.15, pp.7828-7835, 2011.
DOI : 10.1128/JVI.00648-11

V. Goldschmidt, G. Bleiber, M. May, R. Martinez, M. Ortiz et al., Role of common human TRIM5alpha variants in HIV-1 disease progression, Retrovirology, vol.3, issue.1, p.54, 2006.
DOI : 10.1186/1742-4690-3-54

H. Javanbakht, P. An, B. Gold, D. Petersen, O. Huigin et al., Effects of human TRIM5?? polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection, Virology, vol.354, issue.1, pp.15-27, 2006.
DOI : 10.1016/j.virol.2006.06.031

F. Liu, Y. Qiu, H. Li, Y. Kuang, X. Tang et al., An HIV-1 Resistance Polymorphism in TRIM5?? Gene Among Chinese Intravenous Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.56, issue.4, pp.306-311, 2011.
DOI : 10.1097/QAI.0b013e318205a59b

T. Nakajima, E. Nakayama, G. Kaur, H. Terunuma, J. Mimaya et al., Impact of novel TRIM5?? variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection, AIDS, vol.23, issue.16, pp.2091-2100, 2009.
DOI : 10.1097/QAD.0b013e328331567a

E. Nakayama, W. Carpentier, D. Costagliola, T. Shioda, A. Iwamoto et al., Wild type and H43Y variant of human TRIM5?? show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro, Immunogenetics, vol.15, issue.6, pp.511-515, 2007.
DOI : 10.1007/s00251-007-0217-7

H. Price, P. Lacap, J. Tuff, C. Wachihi, J. Kimani et al., A TRIM5?? exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort, AIDS, vol.24, issue.12, pp.1813-1821, 2010.
DOI : 10.1097/QAD.0b013e32833b5256

S. Sawyer, L. Wu, J. Akey, M. Emerman, and H. Malik, High-Frequency Persistence of an Impaired Allele of the Retroviral Defense Gene TRIM5?? in Humans, Current Biology, vol.16, issue.1, pp.95-100, 2006.
DOI : 10.1016/j.cub.2005.11.045

E. Speelmon, D. Livingston-rosanoff, S. Li, Q. Vu, J. Bui et al., Genetic Association of the Antiviral Restriction Factor TRIM5?? with Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.80, issue.5, pp.2463-2471, 2006.
DOI : 10.1128/JVI.80.5.2463-2471.2006

D. Van-manen, M. Rits, C. Beugeling, K. Van-dort, H. Schuitemaker et al., The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection, PLoS Pathogens, vol.75, issue.2, 2008.
DOI : 1464-3510(1988)075[0800:ASBPFM]2.0.CO;2

A. Saez-cirion, C. Hamimi, A. Bergamaschi, A. David, P. Versmisse et al., Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-964, 2011.
DOI : 10.1182/blood-2010-12-327106
URL : https://hal.archives-ouvertes.fr/pasteur-01420583

J. Watts, K. Dang, R. Gorelick, C. Leonard, J. Bess et al., Architecture and secondary structure of an entire HIV-1 RNA genome, Nature, vol.14, issue.7256, pp.711-716, 2009.
DOI : 10.1038/nature08237